Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV – Get Free Report)’s share price was down 2% during trading on Monday . The stock traded as low as $0.50 and last traded at $0.50. Approximately 1,080 shares traded hands during trading, an increase of 513% from the average daily volume of 176 shares. The stock had previously closed at $0.51.
Mosaic ImmunoEngineering Stock Down 11.2%
The business’s 50 day moving average is $0.54 and its 200-day moving average is $0.57.
About Mosaic ImmunoEngineering
Mosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. The company leverages virus-like particles derived from the cowpea mosaic virus (CPMV) to serve as both antigen carriers and immune stimulators, aiming to enhance the magnitude and durability of immune responses. By engineering these plant-based VLPs to display target antigens or adjuvant properties, Mosaic ImmunoEngineering seeks to create differentiated candidates for oncology indications and infectious disease prevention.
Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development.
Featured Stories
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
